Optimizing immunotherapy for head and neck squamous cell carcinoma: recent advances and future directions

The integration of immunotherapy with traditional treatment modalities represents a significant advancement in the management of HNSCC. Future research should prioritize the identification of patient populations that are most likely to respond to these combined therapies, as well as the optimization of treatment protocols to enhance clinical outcomes.